Search Results - "Ruan, Guo-Rui"

The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemia.

Authors: Gao, Meng-Ge Ruan, Guo-Rui Chang, Ying-Jun et al.

Source: Annals of Hematology. Jan2020, Vol. 99 Issue 1, p73-82. 10p.

This result is not displayed to guests.
Login for full access.

Purification, identification, and synthesis of five novel antioxidant peptides from Chinese chestnut (Castanea mollissima Blume) protein hydrolysates.

Authors: Feng, Yan-Xia Ruan, Guo-Rui Jin, Feng et al.

Source: LWT - Food Science & Technology. Jun2018, Vol. 92, p40-46. 7p.

Subjects: Peptide analysis, Peptide synthesis, Chinese chestnut, Gel permeation chromatography, Reverse phase liquid chromatography

A novel stealth liposomal topotecan with amlodipine: Apoptotic effect is associated with deletion of intracellular Ca²⁺ by amlodipine thus leading to an enhanced antitumor activity in leukemia

Authors: Li, Xing Ruan, Guo-Rui Lu, Wan-Liang et al.

Source: Journal of Controlled Release. May2006, Vol. 112 Issue 2, p186-198. 13p.

Subjects: Calcium antagonists, Liposomes, Apoptosis, Leukemia

Evaluation of the Abelson gene as a control gene for real-time quantitative PCR in multiple myeloma.

Authors: Zhang, Yao Ruan, Guo-Rui

Source: Clinical & Experimental Medicine. Nov2014, Vol. 14 Issue 4, p457-460. 4p.

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia.

Authors: Ruan, Guo-Rui Li, Jin-Lan Qin, Ya-Zhen et al.

Source: Annals of Hematology. Feb2009, Vol. 88 Issue 2, p159-166. 8p. 4 Charts, 3 Graphs.

Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia

Authors: Ruan, Guo-Rui Qin, Ya-Zhen Chen, Shan-Shan et al.

Source: Leukemia Research. Sep2006, Vol. 30 Issue 9, p1159-1165. 7p.

Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice

Authors: Ruan, Guo-Rui Liu, Yan-Rong Chen, Shan-Shan et al.

Source: Leukemia Research. Jul2004, Vol. 28 Issue 7, p763-769. 7p.

Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemia.

Authors: Wu, Li‐Xin Liao, Ming‐Yue Zhao, Ming‐Yue et al.

Source: British Journal of Haematology. Jan2026, Vol. 208 Issue 1, p170-178. 9p.

Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia.

Authors: Lu, Run-Qing Wu, Li-Xin Zhang, Jing et al.

Source: Hematology. Dec 2021, Vol. 26 Issue 1, p9-15. 7p.

Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia.

Authors: Jiang, Hao Liu, Xiao-Hong Kong, Jun et al.

Source: Leukemia & Lymphoma. Dec 2021, Vol. 62 Issue 12, p2949-2956. 8p.

Osteoclast stimulatory transmembrane protein (OC‐STAMP) is a promising molecular prognostic indicator for multiple myeloma.

Authors: Wang, Zi‐Long Liu, Yang Zhou, Ya‐Lan et al.

Source: European Journal of Haematology. Aug2020, Vol. 105 Issue 2, p185-195. 11p.

Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations.

Authors: Deng, Dao-Xing Zhu, Hong-Hu Liu, Yan-Rong et al.

Source: Leukemia & Lymphoma. Sep2019, Vol. 60 Issue 9, p2181-2189. 9p.

Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.

Authors: Wu, Li-Xin Zhao, Ming-Yue Yan, Nan et al.

Source: Clinical & Experimental Medicine. 2024, Vol. 24 Issue 1, p1-11. 11p.

Synergistic antitumoral efficacy of a novel replicative adenovirus SG611-PDCD5 and daunorubicin in human leukemic cells.

Authors: Zhou, Ya-Lan Yao, Qiu-Mei Zhou, Jiao et al.

Source: OncoTargets & Therapy. Aug2018, Vol. 11, p5121-5132. 12p.

NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.

Authors: Liu, Yan-Rong Zhu, Hong-Hu Ruan, Guo-Rui et al.

Source: Leukemia Research. Jul2013, Vol. 37 Issue 7, p737-741. 5p.

A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms.

Authors: Yao, Qiu-Mei Zhou, Jiao Gale, Robert Peter et al.

Source: Hematology. Oct2015, Vol. 20 Issue 9, p517-522. 6p.

Prognostic implications of the detection of measurable residual disease and mutations based on next‐generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.

Authors: Wang, Jing Jiang, Hao Jing, Yu et al.

Source: British Journal of Haematology. Jul2022, Vol. 198 Issue 1, pe3-e8. 6p.

Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms‐like tyrosine kinase 3 internal tandem duplication (FLT3‐ITD).

Authors: Zhou, Ya‐Lan Wu, Li‐Xin Peter Gale, Robert et al.

Source: British Journal of Haematology. Jul2020, Vol. 190 Issue 2, p274-283. 10p. 1 Diagram, 3 Charts, 4 Graphs.

DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia.

Authors: Zhang, Jia‐Min Xu, Yan Gale, Robert P. et al.

Source: British Journal of Haematology. Jul2020, Vol. 190 Issue 1, p67-78. 12p. 1 Diagram, 1 Chart, 4 Graphs.